World's Best Scientists 2026 revealed!
Winette T. A. van der Graaf

Winette T. A. van der Graaf

D-Index & Metrics

Medicine

D-Index
89
Citations
31320
World Ranking
12628
National Ranking
484

Winette T. A. van der Graaf publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Winette T. A. van der Graaf sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 584 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Winette T. A. van der Graaf D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Winette T. A. van der Graaf sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Winette T. A. van der Graaf is affiliated with Erasmus MC in the Netherlands and has contributed extensively to the field of medical research, particularly focusing on sarcomas and oncology-related topics. Their work spans numerous subfields within medicine, with significant contributions to pulmonary and respiratory medicine, oncology, pediatrics, perinatology and child health, rheumatology, and sociology and political science.

The research undertakings of van der Graaf are reflected in a substantial volume of publications covering several main topics. These include:

  • Sarcoma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Family Support in Illness
  • Cancer survivorship and care
  • Vascular Tumors and Angiosarcomas
  • Gastrointestinal Tumor Research and Treatment
  • Soft tissue tumor case studies

van der Graaf has published in a variety of venues, demonstrating a broad engagement within the oncology community. Frequent publication venues include:

  • ESMO Open
  • Annals of Oncology
  • Cancers
  • European Journal of Cancer
  • Journal of Clinical Oncology

Among recent papers, some notable publications are:

  • Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE), 2021, ESMO Open
  • Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities, 2021, Cancer

Collaboration plays a major role in van der Graaf's work, with frequent co-authors including:

  • Olga Husson
  • Winan J. van Houdt
  • Ingrid M.E. Desar
  • Hans Gelderblom
  • Neeltje Steeghs

Best Publications

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Ian Judson;Jaap Verweij;Hans Gelderblom;Jörg T Hartmann;Jörg T Hartmann

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • The impact of parental cancer on children and the family: a review of the literature

    Annemieke Visser;Gea A. Huizinga;Winette T.A. van der Graaf;Harald J. Hoekstra

  • Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

    Patrick J. Perik;Marjolijn N. Lub-De Hooge;Jourik A. Gietema;Winette T.A. van der Graaf

  • An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)

    B Kasper;C Baumgarten;J Garcia;S Bonvalot

  • Mycobacterium ulcerans infection

    Tjip S Van der Werf;Winette Ta Van der Graaf;Jordan W Tappero;Kingsley Asiedu

  • The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients

    Ben Alman;Steven Attia;Christina Baumgarten;Charlotte Benson

  • Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins

    Boudewijn E. C. Plaat;Harry Hollema;Willemina M. Molenaar;Gerben H. Torn Broers

  • Mycobacterium ulcerans disease

    Tjip S. van der Werf;Ymkje Stienstra;R. Christian Johnson;Richard Phillips

  • Spinal extradural metastasis: review of current treatment options.

    Ronald H. M. A. Bartels;Yvette M. van der Linden;Winette T. A. van der Graaf

  • Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

    Piotr Rutkowski;Alessandro Gronchi;Peter Hohenberger;Sylvie Bonvalot

  • Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis

    Philippe A. Cassier;Hans Gelderblom;Silvia Stacchiotti;David Thomas

  • Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases

    Jan Willem B de Groot;Bart Rikhof;Jaap van Doorn;Henk J G Bilo

  • Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

    S J Strauss;A M Frezza;N Abecassis;J Bajpai

  • Starting an Adolescent and Young Adult Program: Some Success Stories and Some Obstacles to Overcome

    Andrea Ferrari;David Thomas;Anna R.K. Franklin;Brandon M. Hayes-Lattin

  • Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.

    Lioe-Fee de Geus-Oei;Dennis Vriens;Hanneke W.M. van Laarhoven;Winette T.A. van der Graaf

  • Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility

    Mirjam M. de Jong;Ilja M. Nolte;Gerard J. te Meerman;Winette T. A. van der Graaf

  • Acute Chemotherapy-Induced Cardiovascular Changes in Patients With Testicular Cancer

    Janine Nuver;Andries J. Smit;Jan van der Meer;Maarten P. van den Berg

  • Mycobacterium ulcerans i n f e c t i o n

    Tjip S van der Werf;Winette T A van der Graaf;Jordan W Tappero;Kingsley Asiedu

Frequent Co-Authors

Hans Gelderblom
Hans Gelderblom Leiden University Medical Center
Wim J.G. Oyen
Wim J.G. Oyen Humanitas University
Elisabeth G.E. de Vries
Elisabeth G.E. de Vries University Medical Center Groningen
Harald J. Hoekstra
Harald J. Hoekstra University Medical Center Groningen
Judith B. Prins
Judith B. Prins Radboud University
Otto C. Boerman
Otto C. Boerman Radboud University
Ian Judson
Ian Judson Institute of Cancer Research
Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Stefan Sleijfer
Stefan Sleijfer Erasmus University Rotterdam
Josette E. H. M. Hoekstra-Weebers
Josette E. H. M. Hoekstra-Weebers University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always require following the traditional path to become a doctor. There are many flexible and accessible alternatives worth exploring. For example, those with a bachelor’s degree in a non-nursing field can now pursue msn direct entry programs online, allowing for an accelerated transition into nursing leadership roles.

If you’re looking for programs that are more accessible, you may want to explore what is the easiest nursing program to get into. Choosing such programs may reduce barriers related to competitive admissions or high academic requirements.

Additionally, not everyone interested in healthcare wants to provide direct patient care. There are rewarding opportunities in allied fields, such as medical administration. You can research online medical billing and coding schools that accept fafsa for more affordable, accredited options.

Some nursing programs have removed standardized test requirements. If you wish to avoid entrance exams, consider a nursing school no entrance exam for a more streamlined application process.

Best Scientists Citing Winette T. A. van der Graaf

Trending Scientists